According to Fortune Business Insights, the global Genomics Market Size was valued at USD 34.23 billion in 2025 and is projected to grow from USD 38.24 billion in 2026 to USD 99.26 billion by 2034, exhibiting a CAGR of 12.66% during the forecast period. North America dominated the genomics market with a market share of 43.04% in 2025.

The Genomics Market Size is expanding as advancements in sequencing technologies, molecular biology, and genomic data analysis transform healthcare, biotechnology, and life sciences research. Genomics involves the study of an organism’s complete genetic material, including the structure, function, mapping, and editing of genes. It supports the identification of genetic variations associated with diseases and helps researchers understand biological processes at the molecular level. Growing demand for precision medicine, early disease detection, personalized treatment, and advanced diagnostic solutions is encouraging the adoption of genomic technologies. Increasing investments in research and development, along with the integration of artificial intelligence and bioinformatics, are further strengthening the market.

Continue reading for more details:

https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Market Segmentation

The Genomics Market Size can be segmented by product and service, technology, application, and end user. Based on product and service, the market includes instruments and systems, consumables, software, and services. Instruments and systems are essential for conducting genomic analysis, sequencing, and sample processing. Consumables such as reagents, kits, and laboratory materials are widely used in genomic workflows. Software supports genomic data processing, interpretation, visualization, and storage, while services include sequencing, testing, data analysis, and research support.

Based on technology, the market includes sequencing, polymerase chain reaction, microarray, nucleic acid extraction and purification, and other technologies. Sequencing plays an important role in identifying genetic variations and understanding complex biological conditions. Next-generation sequencing is increasingly used because it enables researchers to analyze genetic information efficiently and supports applications in clinical diagnostics, drug discovery, and population studies. Polymerase chain reaction remains important for amplifying specific DNA sequences, while microarray technology supports gene expression analysis and genetic profiling. Nucleic acid extraction and purification technologies provide the quality genetic material required for accurate genomic testing.

By application, the Genomics Market Size covers diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other research applications. Diagnostics represents a significant application area because genomic testing helps identify inherited disorders, cancer-related mutations, infectious diseases, and other medical conditions. Drug discovery and development use genomic information to understand disease mechanisms, identify therapeutic targets, and evaluate treatment responses. Personalized medicine applies genetic insights to support treatment decisions based on individual biological characteristics. Genomics is also used in agriculture to improve crop traits, enhance productivity, and support research into animal genetics.

Based on end user, the market includes pharmaceutical and biotechnology companies, academic and research institutions, hospitals and clinics, diagnostic laboratories, and other users. Pharmaceutical and biotechnology companies use genomic technologies to support drug development and biomarker discovery. Academic and research institutions apply genomic tools to investigate biological systems and genetic conditions. Hospitals, clinics, and diagnostic laboratories increasingly use genomic testing to support clinical decision-making and disease diagnosis.

Key Players

The Genomics Market Size includes established life science companies, sequencing technology providers, biotechnology businesses, and specialized genomic service companies. Market participants are focusing on technological innovation, strategic collaborations, acquisitions, and the expansion of sequencing and data-analysis capabilities. Key players operating in the market include: